$CBRE
CBRE GROUP, INC. Stock $cbre

$cbre Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000113811822000018 Filed on May 09, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$7.333B	$5.939B
YoY Change	23.47%	0.84%
Cost Of Revenue	$5.752B	$4.720B
YoY Change	21.88%	0.15%
Gross Profit	$1.581B	$1.219B
YoY Change	29.64%	3.64%
Gross Profit Margin	21.56%	20.53%
Selling, General & Admin	$1.066B	$828.3M
YoY Change	28.7%	4.83%
% of Gross Profit	67.44%	67.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$149.0M	$122.1M
YoY Change	22.06%	7.29%
% of Gross Profit	9.43%	10.01%
Operating Expenses	$1.215B	$950.5M
YoY Change	27.83%	5.16%
Operating Profit	$377.0M	$269.1M
YoY Change	40.09%	22.15%
Interest Expense	$30.05M	$73.50M
YoY Change	-59.12%	1497.83%
% of Operating Profit	7.97%	27.31%
Other Income/Expense, Net	-$14.46M	$2.732M
YoY Change	-629.43%	-1515.54%
Pretax Income	$392.5M	$345.3M
YoY Change	13.68%	53.67%
Income Tax	-$3.738M	$76.33M
% Of Pretax Income	-0.95%	22.1%
Net Earnings	$392.3M	$266.2M
YoY Change	47.37%	54.59%
Net Earnings / Revenue	5.35%	4.48%
Basic Earnings Per Share	$1.18	$0.79
Diluted Earnings Per Share	$1.16	$0.78
COMMON SHARES
Basic Shares Outstanding	331.9M shares	335.9M shares
Diluted Shares Outstanding	337.1M shares	339.6M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.657B	$1.910B
YoY Change	-13.23%	204.14%
Cash & Equivalents	$1.657B	$1.910B
Short-Term Investments
Other Short-Term Assets	$543.4M	$318.7M
YoY Change	70.5%	-53.27%
Inventory
Prepaid Expenses	$333.7M	$281.7M
Receivables	$5.073B	$4.233B
Other Receivables	$1.239B	$758.0M
Total Short-Term Assets	$9.334B	$7.906B
YoY Change	18.05%	8.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$792.7M	$774.3M
YoY Change	2.38%	-59.18%
Goodwill	$4.977B	$3.805B
YoY Change	30.81%	3.56%
Intangibles	$2.339B	$1.370B
YoY Change	70.64%
Long-Term Investments	$1.124B	$682.6M
YoY Change	64.72%	61.36%
Other Assets	$869.7M	$748.6M
YoY Change	16.17%	8.28%
Total Long-Term Assets	$11.81B	$9.342B
YoY Change	26.41%	11.0%
TOTAL ASSETS
Total Short-Term Assets	$9.334B	$7.906B
Total Long-Term Assets	$11.81B	$9.342B
Total Assets	$21.14B	$17.25B
YoY Change	22.58%	10.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.882B	$2.469B
YoY Change	16.72%	4.4%
Accrued Expenses	$2.706B	$2.218B
YoY Change	22.01%	4.87%
Deferred Revenue	$295.6M	$174.4M
YoY Change	69.5%	62.99%
Short-Term Debt	$1.413B	$681.0M
YoY Change	107.48%	-46.12%
Long-Term Debt Due	$37.08M	$1.402M
YoY Change	2544.51%	-18.39%
Total Short-Term Liabilities	$7.790B	$5.773B
YoY Change	34.94%	-4.82%
LONG-TERM LIABILITIES
Long-Term Debt	$1.526B	$1.848B
YoY Change	-17.43%	5.35%
Other Long-Term Liabilities	$950.2M	$608.8M
YoY Change	56.07%	31.87%
Total Long-Term Liabilities	$2.476B	$2.457B
YoY Change	0.78%	10.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.790B	$5.773B
Total Long-Term Liabilities	$2.476B	$2.457B
Total Liabilities	$11.86B	$9.593B
YoY Change	23.64%	0.86%
SHAREHOLDERS EQUITY
Retained Earnings	$8.759B	$6.796B
YoY Change	28.88%	14.22%
Common Stock	$412.5M	$1.017B
YoY Change	-59.43%	-1.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.470B	$7.230B
YoY Change
Total Liabilities & Shareholders Equity	$21.14B	$17.25B
YoY Change	22.58%	10.0%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$392.3M	$266.2M
YoY Change	47.37%	54.59%
Depreciation, Depletion And Amortization	$149.0M	$122.1M
YoY Change	22.06%	7.29%
Cash From Operating Activities	-$393.5M	-$193.4M
YoY Change	103.42%	50.22%
INVESTING ACTIVITIES
Capital Expenditures	$42.06M	$29.60M
YoY Change	42.1%	-52.45%
Acquisitions
YoY Change
Other Investing Activities	$4.487M	-$16.00K
YoY Change	-28143.75%	-99.82%
Cash From Investing Activities	-$95.62M	-$193.9M
YoY Change	-50.69%	110.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$367.9M	$61.11M
YoY Change	501.99%	22.15%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$209.0M	$402.0M
YoY Change	-152.0%	-496.37%
NET CHANGE
Cash From Operating Activities	-$393.5M	-$193.4M
Cash From Investing Activities	-$95.62M	-$193.9M
Cash From Financing Activities	-$209.0M	$402.0M
Net Change In Cash	-$747.2M	-$37.54M
YoY Change	1890.28%	-89.6%
FREE CASH FLOW
Cash From Operating Activities	-$393.5M	-$193.4M
Capital Expenditures	$42.06M	$29.60M
Free Cash Flow	-$435.6M	-$223.0M
YoY Change	95.28%	16.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001138118
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2022Q1	dei	Entity File Number EntityFileNumber	001-32205
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	CBRE GROUP, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3391143
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2100 McKinney Avenue
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1250
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75201
CY2022Q1	dei	City Area Code CityAreaCode	214
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	979-6100
CY2022Q1	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.01 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	“CBRE”
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	326860554	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1657336000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2430951000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	135293000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	108830000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	93667000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	97588000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5073224000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5150473000	USD
CY2022Q1	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	1194800000	USD
CY2021Q4	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	1303717000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	333672000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	333885000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	352064000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	338749000	USD
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	43758000	USD
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	44104000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	543400000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	371656000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	9333547000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	10082365000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1330999000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1288509000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	792735000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	816092000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	4977082000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	4995175000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1741193000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1725280000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2338548000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2409427000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1030391000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1046377000	USD
CY2022Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	713871000	USD
CY2021Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	813031000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1124339000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1196088000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	134324000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	135626000	USD
CY2022Q1	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	361852000	USD
CY2021Q4	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	326416000	USD
CY2022Q1	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	37907000	USD
CY2021Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	33150000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	142748000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	157032000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	869679000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	875743000	USD
CY2022Q1	us-gaap	Assets Assets	21143152000	USD
CY2021Q4	us-gaap	Assets Assets	22073491000	USD
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2881910000	USD
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2916331000	USD
CY2022Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1579118000	USD
CY2021Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1539291000	USD
CY2022Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	906343000	USD
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1694590000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	220730000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	232423000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	295642000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	280659000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	268823000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	246035000	USD
CY2022Q1	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	1172125000	USD
CY2021Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	1277451000	USD
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	210000000	USD
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2022Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	30826000	USD
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	32668000	USD
CY2022Q1	us-gaap	Debt Current DebtCurrent	1412951000	USD
CY2021Q4	us-gaap	Debt Current DebtCurrent	1310119000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	224327000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	199421000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7789844000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8418869000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1526212000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1538123000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1104812000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1116562000	USD
CY2022Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	124348000	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	144884000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	54761000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	54761000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	310104000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	405258000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	950246000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1035917000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	11860327000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	12714374000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	525000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	332875959	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	525000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	329555402	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	329555402	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	332875959	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	3296000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3329000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	409187000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	798892000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8758928000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8366631000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-701440000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-640659000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8469971000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8528193000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	812854000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	830924000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9282825000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9359117000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21143152000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22073491000	USD
CY2022Q1	us-gaap	Revenues Revenues	7332933000	USD
CY2021Q1	us-gaap	Revenues Revenues	5938879000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	5752194000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	4719546000	USD
CY2022Q1	cbre	Operating Administrative And Other Expenses OperatingAdministrativeAndOtherExpenses	1065996000	USD
CY2021Q1	cbre	Operating Administrative And Other Expenses OperatingAdministrativeAndOtherExpenses	828327000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149032000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	122078000	USD
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10351000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2022Q1	cbre	Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets	6977573000	USD
CY2021Q1	cbre	Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets	5669951000	USD
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	21592000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	156000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	376952000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	269084000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42871000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	83594000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14464000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2732000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12826000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-10106000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	392533000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	345304000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3738000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76327000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3974000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2775000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	392297000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	266202000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.18
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	331925104	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335860494	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	337140325	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	339580504	shares
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-81285000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-52346000	USD
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-108000	USD
CY2021Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-107000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1731000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-678000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	100000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-82808000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-52917000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	313463000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	216060000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-18053000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2667000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	331516000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	213393000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149032000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	122078000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1663000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1609000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	28422000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	72045000	USD
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10351000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-16690000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	2732000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3303000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	731000	USD
CY2022Q1	cbre	Share Based Compensation Expense Reversal ShareBasedCompensationExpenseReversal	-36863000	USD
CY2021Q1	cbre	Share Based Compensation Expense Reversal ShareBasedCompensationExpenseReversal	-35786000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42871000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	83594000	USD
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	146743000	USD
CY2021Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	32986000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	3336084000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4643685000	USD
CY2022Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3221312000	USD
CY2021Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3909261000	USD
CY2022Q1	cbre	Increase Decrease In Warehouse Lines Of Credit IncreaseDecreaseInWarehouseLinesOfCredit	-105326000	USD
CY2021Q1	cbre	Increase Decrease In Warehouse Lines Of Credit IncreaseDecreaseInWarehouseLinesOfCredit	-708491000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-2114000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-1578000	USD
CY2022Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	8902000	USD
CY2021Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	2398000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	20750000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	3017000	USD
CY2022Q1	cbre	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	41358000	USD
CY2021Q1	cbre	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	15901000	USD
CY2022Q1	cbre	Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets	156061000	USD
CY2021Q1	cbre	Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets	-161221000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-108355000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-245522000	USD
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-725216000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-469213000	USD
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-17722000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-41660000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	93270000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-2381000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-393507000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-193448000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42056000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29597000	USD
CY2022Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	16792000	USD
CY2021Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	2726000	USD
CY2022Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	44387000	USD
CY2021Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	168392000	USD
CY2022Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	12101000	USD
CY2021Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	6795000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4487000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-16000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-95621000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-193904000	USD
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	210000000	USD
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2022Q1	cbre	Proceeds From Notes Payable On Real Estate ProceedsFromNotesPayableOnRealEstate	19368000	USD
CY2021Q1	cbre	Proceeds From Notes Payable On Real Estate ProceedsFromNotesPayableOnRealEstate	23737000	USD
CY2022Q1	cbre	Repayment Of Notes Payable On Real Estate RepaymentOfNotesPayableOnRealEstate	13954000	USD
CY2021Q1	cbre	Repayment Of Notes Payable On Real Estate RepaymentOfNotesPayableOnRealEstate	0	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	492255000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	367863000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	61108000	USD
CY2022Q1	cbre	Payments To Acquire Business Financing Activities PaymentsToAcquireBusinessFinancingActivities	13556000	USD
CY2021Q1	cbre	Payments To Acquire Business Financing Activities PaymentsToAcquireBusinessFinancingActivities	512000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	31395000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	34883000	USD
CY2022Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	210000	USD
CY2021Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	72000	USD
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	213000	USD
CY2021Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2652000	USD
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-11606000	USD
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-14943000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-209009000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	401966000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-49015000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-52154000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-747152000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37540000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2539781000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2039247000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1792629000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2001707000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	12826000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	15080000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	88649000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	38508000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9359117000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	36863000	USD
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	31395000	USD
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	390863000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-81285000	USD
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-108000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1731000	USD
CY2022Q1	cbre	Noncontrolling Interest Increase From Contributions From Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsFromNoncontrollingInterestHolders	210000	USD
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	213000	USD
CY2022Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	4257000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9282825000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7120087000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35786000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	34883000	USD
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	64142000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-52346000	USD
CY2021Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-107000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-678000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-38835000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	0	USD
CY2021Q1	cbre	Noncontrolling Interest Increase From Contributions From Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsFromNoncontrollingInterestHolders	72000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2652000	USD
CY2021Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1056000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7271384000	USD
CY2022Q1	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Readers of this Quarterly Report on Form 10-Q (Quarterly Report) should refer to the audited financial statements and notes to consolidated financial statements of CBRE Group, Inc., a Delaware corporation (which may be referred to in these financial statements as “the company,” “we,” “us” and “our”), for the year ended December 31, 2021, which are included in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001138118/000113811822000010/cbre-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Annual Report on Form 10-K (2021 Annual Report)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the United States Securities and Exchange Commission (SEC) and also available on our website (www.cbre.com), since we have omitted from this Quarterly Report certain footnote disclosures which would substantially duplicate those contained in such audited financial statements. You should also refer to Note 2, Significant Accounting Policies, in the notes to consolidated financial statements in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001138118/000113811822000010/cbre-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of our significant accounting policies and estimates.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Considerations Related to the Covid-19 Pandemic and the war in Ukraine</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2010 to early 2020, commercial real estate markets had generally been characterized by increased demand for space, falling vacancies, higher rents and strong capital flows, leading to solid property sales and leasing activity. This healthy backdrop changed abruptly in the first quarter of 2020 with the emergence of the novel coronavirus (Covid-19) and resultant sharp contraction of economic activity across much of the world. There was a significant impact on commercial real estate markets, as many property owners and occupiers put transactions on hold and withdrew existing mandates, sharply reducing sales and leasing volumes. Subsequently commercial real estate markets recovered strongly beginning in 2021 and continuing into the first quarter of 2022. However, it is expected the pandemic has structurally changed the utilization of many types of commercial real estate, which is likely to impact our business. In addition, Russia’s invasion of Ukraine on February 24, 2022 and the ongoing military conflict poses heightened risk, particularly for our operations in central and eastern Europe, and could exacerbate macro-economic challenges, including supply chain disruptions and persistently high inflation, as well as adversely affect business and/or consumer sentiment and overall economic growth. As a result of this conflict, we elected to exit most of our business in Russia, although we have a limited number of employees managing facilities for existing global clients that continue to operate there.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 10 (Commitments and Contingencies) for further discussion of Covid-19 considerations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statement Preparation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with the rules applicable to quarterly reports on Form 10-Q and include all information and footnotes required for interim financial statement presentation, but do not include all disclosures required under accounting principles generally accepted in the United States (U.S.), or General Accepted Accounting Principles (GAAP), for annual financial statements. In our opinion, all adjustments (consisting of normal recurring adjustments, except as otherwise noted) considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions about future events, including the impact Covid-19 and the war in Ukraine may have on our business. These estimates and the underlying assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Such estimates include the value of goodwill, intangibles and other long-lived assets, real estate assets, accounts receivable, contract assets, operating lease assets, investments in unconsolidated subsidiaries and assumptions used in the calculation of income taxes, retirement and other post-employment benefits, among others. These estimates and assumptions are based on our best judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.</span></div>
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions about future events, including the impact Covid-19 and the war in Ukraine may have on our business. These estimates and the underlying assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Such estimates include the value of goodwill, intangibles and other long-lived assets, real estate assets, accounts receivable, contract assets, operating lease assets, investments in unconsolidated subsidiaries and assumptions used in the calculation of income taxes, retirement and other post-employment benefits, among others. These estimates and assumptions are based on our best judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.
CY2021Q4	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	1303717000	USD
CY2022Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3221312000	USD
CY2022Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	8134000	USD
CY2022Q1	cbre	Sale Of Mortgage Loans Held For Sale SaleOfMortgageLoansHeldForSale	3327950000	USD
CY2022Q1	us-gaap	Proceeds From Collection Of Mortgage Loans Held For Sale ProceedsFromCollectionOfMortgageLoansHeldForSale	8134000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	3336084000	USD
CY2022Q1	cbre	Net Increase Decrease In Mortgage Servicing Rights Included In Warehouse Receivables NetIncreaseDecreaseInMortgageServicingRightsIncludedInWarehouseReceivables	-2279000	USD
CY2022Q1	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	1194800000	USD
CY2022Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue	167600000	USD
CY2021Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue	152700000	USD
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	406690000	USD
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10700000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	-9378000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	367855000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1322000	USD
CY2022Q1	cbre	Other Liabilities Measurement Input OtherLiabilitiesMeasurementInput	0.250
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10400000	USD
CY2022Q1	cbre	Notes Payable On Real Estate NotesPayableOnRealEstate	53600000	USD
CY2021Q4	cbre	Notes Payable On Real Estate NotesPayableOnRealEstate	48200000	USD
CY2022Q1	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.500
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1124339000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1196088000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1533611000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1545859000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7399000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7736000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1526212000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1538123000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1030391000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1046377000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	107942000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	110809000	USD
CY2022Q1	cbre	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	1138333000	USD
CY2021Q4	cbre	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	1157186000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	220730000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	232423000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	37076000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	38103000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1104812000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1116562000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	70750000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	73257000	USD
CY2022Q1	cbre	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	1433368000	USD
CY2021Q4	cbre	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	1460345000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	14784000	USD
CY2021Q1	cbre	Other Noncash Increases Decreases In Finance Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets	-1563000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	24214000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9415000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	10448000	USD
CY2022Q1	cbre	Other Noncash Increases Decreases In Operating Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets	25346000	USD
CY2021Q1	cbre	Other Noncash Increases Decreases In Operating Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets	5940000	USD
CY2022Q1	cbre	Other Noncash Increases Decreases In Finance Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets	-989000	USD
CY2022Q1	cbre	Funded Loan Principal Amount Outstanding FundedLoanPrincipalAmountOutstanding	35800000000	USD
CY2022Q1	cbre	Loan Loss Sharing Reserve LoanLossSharingReserve	64600000	USD
CY2021Q4	cbre	Loan Loss Sharing Reserve LoanLossSharingReserve	64000000	USD
CY2022Q1	cbre	Assets Available For Recourse AssetsAvailableForRecourse	764200000	USD
CY2022Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	169600000	USD
CY2022Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	169600000	USD
CY2022Q1	cbre	Guarantor Obligations Maximum Exposure Undiscounted GuarantorObligationsMaximumExposureUndiscounted	46400000	USD
CY2022Q1	cbre	Guarantor Obligations Maximum Exposure Undiscounted GuarantorObligationsMaximumExposureUndiscounted	46400000	USD
CY2022Q1	cbre	Percentage Of Equity In Real Estate Investment PercentageOfEquityInRealEstateInvestment	0.020
CY2022Q1	cbre	Commitments To Investment In Future Real Estate Investment CommitmentsToInvestmentInFutureRealEstateInvestment	115200000	USD
CY2022Q1	cbre	Commitments To Investment In Unconsolidated Entity CommitmentsToInvestmentInUnconsolidatedEntity	49700000	USD
CY2022Q1	cbre	Commitments To Investment In Consolidated Projects CommitmentsToInvestmentInConsolidatedProjects	100900000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3700000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76300000	USD
CY2022Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-80100000	USD
CY2021Q1	cbre	Discrete Net Income Tax Expense Benefit DiscreteNetIncomeTaxExpenseBenefit	-82200000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.010
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.221
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022Q1	cbre	Discrete Net Income Tax Expense Benefit DiscreteNetIncomeTaxExpenseBenefit	-82200000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	331200000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	191900000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	139300000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	392297000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	266202000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	331925104	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335860494	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.18
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	392297000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	266202000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	331925104	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335860494	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	5215221	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3720010	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	337140325	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	339580504	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	1590000000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7168411000	USD
CY2022Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	164522000	USD
CY2022Q1	us-gaap	Revenues Revenues	7332933000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5778432000	USD
CY2021Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	160447000	USD
CY2021Q1	us-gaap	Revenues Revenues	5938879000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	486400000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	352100000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	474400000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	338700000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	303700000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	295600000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	288900000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	280700000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	77500000	USD
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022Q1	us-gaap	Revenues Revenues	7332933000	USD
CY2021Q1	us-gaap	Revenues Revenues	5938879000	USD
CY2022Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	835442000	USD
CY2021Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	547829000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	392297000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	266202000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3974000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2775000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149032000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	122078000	USD
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10351000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12826000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-10106000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3738000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76327000	USD
CY2022Q1	cbre	Carried Interest Incentive Compensation Expense Reversal CarriedInterestIncentiveCompensationExpenseReversal	22856000	USD
CY2021Q1	cbre	Carried Interest Incentive Compensation Expense Reversal CarriedInterestIncentiveCompensationExpenseReversal	15332000	USD
CY2022Q1	cbre	Impact Of Fair Value Adjustments To Assets Acquired In Business ImpactOfFairValueAdjustmentsToAssetsAcquiredInBusiness	-1696000	USD
CY2021Q1	cbre	Impact Of Fair Value Adjustments To Assets Acquired In Business ImpactOfFairValueAdjustmentsToAssetsAcquiredInBusiness	1099000	USD
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	1676000	USD
CY2021Q1	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2022Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	8121000	USD
CY2021Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	0	USD
CY2022Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	835442000	USD
CY2021Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	547829000	USD
CY2022Q1	us-gaap	Revenues Revenues	7332933000	USD
CY2021Q1	us-gaap	Revenues Revenues	5938879000	USD

Files In Submission

Name	View Source	Status
0001138118-22-000018-index-headers.html	Edgar Link	pending
0001138118-22-000018-index.html	Edgar Link	pending
0001138118-22-000018.txt	Edgar Link	pending
0001138118-22-000018-xbrl.zip	Edgar Link	pending
cbre-20220331.htm	Edgar Link	pending
cbre-20220331.xsd	Edgar Link	pending
cbre-20220331x10qxex221.htm	Edgar Link	pending
cbre-20220331x10qxex311.htm	Edgar Link	pending
cbre-20220331x10qxex312.htm	Edgar Link	pending
cbre-20220331x10qxex32.htm	Edgar Link	pending
cbre-20220331_cal.xml	Edgar Link	unprocessable
cbre-20220331_def.xml	Edgar Link	unprocessable
cbre-20220331_g1.jpg	Edgar Link	pending
cbre-20220331_htm.xml	Edgar Link	completed
cbre-20220331_lab.xml	Edgar Link	unprocessable
cbre-20220331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBRE
CBRE GROUP, INC. Stock $cbre

2022 Q1 Form 10-Q Financial Statement

#000113811822000018 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBRE CBRE GROUP, INC. Stock $cbre

2022 Q1 Form 10-Q Financial Statement

#000113811822000018 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBRE
CBRE GROUP, INC. Stock $cbre